Business Wire: September 13, 2017 – LOS ANGELES, CA, U.S.A. – Biosciences, Inc., a bio-targeted nanomedicines company developing a novel nanoparticle drug delivery platform, with a proprietary oncology pipeline, announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 9,757,…
